Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Benxi Sanyao Co., Ltd. is a prominent pharmaceutical manufacturing subsidiary of China Resources Sanjiu Medical & Pharmaceutical, based in Benxi, Liaoning Province. The company specializes in the development and production of Traditional Chinese Medicine (TCM) and chemical drugs, with a core focus on gastrointestinal and cardiovascular health. Its most recognized product, Qizhi Weitong Granules, is a leading treatment for stomach-related conditions in China. Operating under the "999" brand umbrella of its parent company, China Resources Benxi Sanyao maintains high-standard GMP manufacturing facilities and contributes significantly to the group's TCM portfolio. The company leverages the extensive distribution and R&D network of the China Resources Group to maintain its market position. It is recognized as a key high-tech enterprise within its region, focusing on the modernization of traditional medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Benxi Sanyao.